echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Alzheimer's and Dementia: The relationship between baseline amyloid proteins and neurofiber tau deposition in β-age Down syndrome (NiAD).

    Alzheimer's and Dementia: The relationship between baseline amyloid proteins and neurofiber tau deposition in β-age Down syndrome (NiAD).

    • Last Update: 2020-11-04
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    The diagnosis of Alzheimer's disease (AD) depends on the appearance of amyloid β (A beta) plaques and tau-containing nerve fiber tangles during autopsies.
    recently, the emergence of positive electron emission fault scanning (PET) ligations for A beta and tau, such as piB3, and AV-14514, allows us to examine the relationship between cognition and AD pathophysiology in the body.
    these studies have shown that tau pathology is more closely related to cognitive decline than A beta2 and is associated with AD diagnosis, amyloid-positive, and cognitive function.
    adults with Down syndrome (DS) are consistently affected by AD-related pathology, characterized by the development of A-beta plaques in their fourth decade, and they show an increased prevalence of AD.
    From a large amount of data, the overprodomy of amyloid preloom protein (APP) is due in part to chromosome 21 encoding the triple of APP, apparently associated with the high risk of AD in DS and the emergence of clinical AD esoploids at an earlier age.
    recently, researchers published a study in Alzheimer's and Dementia aimed at evaluating the presence of tau in the brains of DS patients using the AV-1451 positive electron emission fault scan (PET) and the relationship between brain tau in Pittsburgh compound B (PiB)-PET.
    study is a multi-center queue study.
    participants included samples of DS patients recruited from the community and their sibling control groups.
    exclusion criteria include magnetic resonance imaging (MRI) disorders and/or medical or psychiatric conditions that impair cognitive function.
    researchers used multiple linear regression models (adjusted by age, sex, and between the manifestation sites) to assess the association between the study area's standard ingestion ratio (SUVR) (based on regions associated with Braak phase 1-6) and the whole brain's (11C) PiB SUVR (as a continuous and disaggregated variable).
    the cohort study studied 156 participants (average age: 39.05 years, SD (8.4)).
    results revealed a significant relationship between A-beta and tau pathology in DS patients.
    as a two-part variable, the AV-1451 remains higher in each Braak region of the PiB (plus) participants.
    the researchers also found that, according to their statistical model, the deposition of the AV-1451 SUVR accelerated, starting with the Area of Interest (ROI) of Braak 3, and the increase of the PiB SUVR.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.